CompletedNCT00168311
Repetitive magnetic stimulation for negative symptoms of schizophrenia
About this title
Read the official source —Device studyAges 18–70Australia
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
- Listed locations
- MelbourneSee all locations and recruitment
Study information
Study start dateAugust 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- 22
- Sponsor
- The Alfred
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- Australia
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT00168311
- Official title
Show the full official title
A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magentic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia and Related Disorders
Get this study by email
Recruitment & locations
CompletedMelbourne
Questions about this study
Who is behind this study?
The study sponsor is The Alfred.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
